Development of mesothelioma-specific oncolytic immunotherapy enabled by immunopeptidomics of murine and human mesothelioma tumors
Article in Nature Communications (November 2023)
The most recent citing publications are shown below. View all 28 publications that cite this research output on Dimensions.
Article in Nature Communications (November 2023)
Article in Scandinavian Journal of Immunology (June 2023)
Article in Seminars in Immunology (May 2023)